Erin O'Brien

The experts weighed in on a wide variety of psychiatric issues for the January 2024 issue of Psychiatric Times.

From noninvasive brain stimulation for substance use disorders to updates from APSARD 2024, here are highlights from the week in Psychiatric Times.

What is new in research on clinician wellness?

The candidate also aims to address neurodevelopmental and neurodegenerative disorders such as Parkinson disease and Rett syndrome.

US suicide rates reached an all-time high in 2022. Here’s how effective implementation of 988 can help address the problem.

From clinician wellness to THC use in adolescents, here are highlights from the week in Psychiatric Times.

The results were shared in a poster presentation at the 2024 APSARD Annual Meeting.

What is new in research on COVID-19 and mental health?

Take a look back at our recent coverage relating to our January content theme.

“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”

From substance use disorders in physicians to new research on the efficacy of MDMA-assisted therapy for PTSD, here are highlights from the week in Psychiatric Times.

What is new in research on sleep?

From a groundbreaking new launch for PTSD in the United States to connections between antidepressant treatment and metabolic syndrome, here are highlights from the week in Psychiatric Times.

What is new in research on posttraumatic stress disorder?

Write to us now to be part of our series focused on clinician wellness this month.

The data assess the extended efficacy of the treatment for up to 4 years.

The device is now available at 2 US clinics, with training and installation currently underway at several other locations.

The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.

Here are some updates from the world of psychiatry throughout the month of December.

What is new in research on seasonal affective disorder?

The experts weighed in on a wide variety of psychiatric issues for the December 2023 issue of Psychiatric Times.

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

Reviewing a year of CMEs in Psychiatric Times®

From new guidelines for the utilization of artificial intelligence in health care to the efficacy of fish oil as a replacement for antidepressants, here are highlights from the week in Psychiatric Times.

What is new in research on schizophrenia?

Did you miss the 2023 Annual Psychiatric Times World CME Conference? Don't worry, we've got you covered.

From a new look at the famous STAR*D study to updates from the National Academy of Sciences Conference on Adult ADHD, here are highlights from the week in Psychiatric Times.

What is new in research on ADHD?

“This is the first study to assess the standalone drug effects of MM-120 in the absence of any psychotherapeutic intervention.”

From adjunctive cariprazine for the treatment of major depressive disorder to a new app for prescribing antidepressants and antipsychotics, here are highlights from the week in Psychiatric Times.